Etanercept for the treatment of rheumatoid arthritis, PMID: 29482402
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis, PMID: 30411183
Etanercept biosimilar SB-4, PMID: 30616405
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial, PMID: 30747501
[Etanercept], PMID: 31204122
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission, PMID: 33205906
GP2015: An Etanercept Biosimilar, PMID: 28940172
Etanercept-induced palisaded neutrophilic granulomatous dermatitis, PMID: 33279312
Etanercept for treating axial spondyloarthritis, PMID: 28682112
Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases, PMID: 27455991
Safety update of etanercept treatment for moderate to severe plaque psoriasis, PMID: 32178543
Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization, PMID: 33043386
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial, PMID: 31122296
Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review, PMID: 32700773
Etanercept in the treatment of psoriatic arthritis, PMID: 25455504
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study, PMID: 28448562
Etanercept for the treatment of non-radiographic axial spondyloarthritis, PMID: 26788837
Etanercept for Treatment of Taxane-Induced Pneumonitis, PMID: 31219735
Erythromycin-induced pemphigus foliaceus successfully treated with etanercept, PMID: 32808715
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis, PMID: 27787890
Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients, PMID: 32623650
[Etanercept-induced subacute thyroiditis. Case report and literature review], PMID: 28942661
Treatment of psoriasis with etanercept: the typical patient profile, PMID: 27073046
Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats, PMID: 32720159
Etanercept as Adjunctive Primary Therapy in Kawasaki Disease, PMID: 31048416
Efficacy and safety of etanercept in the treatment of sciatica: A systematic review and meta-analysis, PMID: 28779960
Etanercept improves aging-induced cognitive deficits by reducing inflammation and vascular dysfunction in rats, PMID: 32569601
Etanercept combined with systemic drugs or phototherapy for treatment of psoriasis, PMID: 25529463
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry, PMID: 33121528
Functional analysis of glycosylation in Etanercept: Effects over potency and stability, PMID: 32682933
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis, PMID: 28837372
TNF-α modulation via Etanercept restores bone regeneration of atrophic non-unions, PMID: 32745691
Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation, PMID: 32194205
Etanercept for Ankylosing Spondylitis With Coexisting Demyelinating Myelitis, PMID: 30199382
Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database, PMID: 26618553
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients, PMID: 30610544
A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature, PMID: 27765165
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up, PMID: 30300358
Can etanercept treatment failure in moderate-to-severe psoriasis be overcome by addition of low-dose methotrexate? A single-center experience, PMID: 29466892
Use of Etanercept for Psoriasis in a Renal Transplant Recipient, PMID: 31627849
Efficacy of etanercept for treating the active rheumatoid arthritis: an updated meta-analysis, PMID: 26354025
Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis, PMID: 28750567
Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case, PMID: 31309782
[Actual treatments of psoriasis : from etanercept to anti-IL17 and anti-IL23 antagonists], PMID: 32496683
Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease, PMID: 32347889
Prophylactic etanercept treatment in cisplatin ototoxicity, PMID: 28730299
Oxaliplatin-Induced Rather Than Taxane-Induced Pneumonitis Was Responsive to Etanercept, PMID: 31682545
Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID-19 pandemic: The real-world experience of a single center, PMID: 33274541
Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars, PMID: 31925703
A successful case of etanercept used for idiopathic granulomatous mastitis, PMID: 30790374
Two Consecutive Days of Low-Dose Methotrexate Toxicity: A Diagnostic Challenge., PMID:40520835
Tumor necrosis factor-alpha in mediation of acute salt loading induced natriuresis in mice; evidence for its physiological role in regulating kidney function., PMID:40517012
Comparison and analysis of biological drug consumption in two Italian hospital settings: Governance actions and prescribing appropriateness., PMID:40494065
Total Knee Arthroplasty in a Patient With Isolated Rheumatoid Arthritis of the Knee., PMID:40491655
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study., PMID:40485573
Pharmacogenomics of TNF inhibitors., PMID:40469293
Evaluation of Factors Associated With Uveitis Onset Timing in Oligoarticular Juvenile Idiopathic Arthritis., PMID:40454975
Etanercept, a peripherally restricted TNF inhibitor, enhances cocaine-induced locomotor behaviors in male, but not female, rats., PMID:40446442
Psoriasis complicated with polymyositis successfully treated with Ixekizumab: A case report., PMID:40441209
Systematic review of comparative studies on emerging psoriasis treatments: comparing biologics with biologics, small molecule inhibitors with small molecule inhibitors, and biologics with small molecule inhibitors., PMID:40439875
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation., PMID:40428231
Comparative efficacy, safety and immunogenicity of biosimilars and their reference biologic drugs in ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials., PMID:40418343
The Relationship Between TNF-α Inhibitor Potency and HBV Reactivation in Patients With Rheumatic Disorders., PMID:40418092
Rapid baseline hump-free analysis of therapeutic proteins in a wide molecular weight range by SDS - capillary agarose gel electrophoresis., PMID:40409905
Coexistent Ankylosing Spondylitis and Ocular Toxocariasis in a Pediatric Patient Manifesting As Bilateral Panuveitis., PMID:40406765
Evaluating changes in baseline characteristics and drug utilisation pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) Cohort., PMID:40402160
Dual therapy for amanita phalloides-induced acute liver failure in mice: A combination of etanercept and alpha-1 antitrypsin., PMID:40398510
Systematic review and meta-analysis of the efficacy of biologic and targeted synthetic therapies in sarcoidosis., PMID:40393718
Identification of therapeutic targets for neonatal respiratory distress: A systematic druggable genome-wide Mendelian randomization., PMID:40388790
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry., PMID:40387427
Ethanol-induced dysfunction of the mesenteric perivascular adipose tissue is driven by mineralocorticoid receptors., PMID:40377659
Cardiovascular Outcomes of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Review of the Current Evidence., PMID:40376321
Efficacy of Tumor Necrosis Factor Inhibitors for Refractory Leg Ulcers in Cutaneous Polyarteritis Nodosa: A Case Series., PMID:40374513
Drug survival and predictor factors for discontinuation of first-line biologic therapy in rheumatoid arthritis: data from a real-world single-centre study., PMID:40371548
Drug-associated infections and infestations in older adults with tumor necrosis factor-alpha inhibitors: a real-world retrospective and pharmacovigilance study., PMID:40371340
Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease., PMID:40358366
Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary., PMID:40353738
Subclinical Enthesitis in Children with Chronic Nonbacterial Osteomyelitis., PMID:40353601
Aggregate Distributional Cost-Effectiveness Analysis of Biologics for the Treatment of Ankylosing Spondylitis in Chile., PMID:40329067
Compatibility between Proteins and Polysaccharide Excipients in Oral Delivery Tablets., PMID:40323221
TNF-α antagonist alleviates muscular layer enlargement but does not prevent myenteric neuronal loss in the colon of streptozotocin-induced diabetic rats., PMID:40288461
Impact of excess weight on clinical features of psoriasis and efficacy of biologic therapies in children with severe psoriasis: Analysis of data from the BiPe cohorts., PMID:40286464
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)., PMID:40279006
The impact of biosimilar use on healthcare utilization among new users of etanercept for inflammatory arthritis: a population-based regression discontinuity analysis., PMID:40270586
Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience., PMID:40264484
Recommendations for the Use of Disease-Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review., PMID:40256995
Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo., PMID:40251677
Characterising infusion/injection-related reactions in patients with rheumatoid arthritis treated with biologic agents., PMID:40249052
Relapsing-remitting multiple sclerosis as a potential consequence of thalidomide treatment: A case report., PMID:40245782
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Current Management and Innovative Therapies., PMID:40231717
Risk of Serious Infections in Patients Treated With Biologic or Targeted-synthetic Disease Modifying Antirheumatic Drugs in Qatar., PMID:40230031
Drug- and Vaccine-Induced Cutaneous T-Cell Lymphoma: A Systematic Review of the Literature., PMID:40226161
Immunotherapy as a treatment for type 1 diabetes mellitus in children and young adults: A comprehensive systematic review and meta-analysis., PMID:40215252
Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis., PMID:40208364
Dual biological treatments in immune-mediated disorders: a single center experience., PMID:40200173
From the Cochrane Library: Anti-tumor necrosis factor agents for pediatric psoriasis., PMID:40187532
Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model., PMID:40181734
Analysis of the Reduction in the Duration of Sick Leave for 32,512 Psoriasis Patients Following the Integration of Targeted Therapies for Psoriatic Disease into the Brazilian Healthcare System: a Retrospective Cohort Study., PMID:40171531
Anti-TNFα as an Adjunctive Therapy in Pancreas and Kidney Transplantation., PMID:40170787
For research use only. Not for human or drug use.
